JD

Jun Deng

VC | Health & Consumer | Board

Palo Alto, California

Invests in

Stages:

  • Min Investment:

    $50,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $500,000.00

Work Experience

  • Partner

    2024

  • Partner

    2018

    Investing in companies that, through science and tech, cultivate joy to improve the way we live.

2024

  • Investor

    2024

    The First & Only Employee Benefit Dedicated to Preventative Skin Health & Wellness.

  • Board Observer

    2023

  • Investor

    2019

    Acquired by 3D System (NYSE:DDD) https://www.businesswire.com/news/home/20211027006115/en/Volumetric-to-Be-Acquired-by-3D-Systems-to-Advance-Tissue-and-Organ-Manufacturing

  • Investor

    2018

    Acquired by Reed Elsevier (NYSE: RELX) https://technical.ly/2021/12/03/osmosis-acquired-elsivier/

  • Investor

    2016

    Acquired by Element Biosciences

  • Investor

    2018

  • Investor

    2018

    Created a strategic partnership between Joyance and HealthTech Capital, optimizing investment opportunities Funded and mentored startups that decrease healthcare costs or empower the patients by leveraging data insights

  • Investment Partner

    2018

    Tracks the social mobile technology is going to have its next big impact Named as the top VCs under 100M by Pitchbook